Quantum Cyber files $100 million at-the-market stock offering
The former Mainz Biomed, now focused on AI and quantum tech for drones, set terms with Titan Partners for shares sold as needed on Nasdaq.
Quantum Cyber N.V., trading on Nasdaq as QUCY, filed a prospectus supplement dated October 9, 2026 for an at-the-market equity program allowing it to sell up to $100,000,000 in ordinary shares over time through agent Titan Partners Securities LLC. The company entered into the sales agreement on October 9, 2026, and Titan Partners will earn a commission equal to 3% of the gross sales price of shares it sells.1 The last reported sale price before the filing was $1.39 per share on October 8, 2026.1
The company describes itself as a technology company focused on developing intelligent, scalable platforms that integrate artificial intelligence and quantum computing to power next-generation control systems for unmanned vehicles, aerial vehicles and underwater vehicles, such as drones, self-driving cars and robotic fleets.1 That marks a pivot from its origins: the company had historically focused on in-vitro diagnostic tests for early cancer detection, and its legacy ColoAlert product was marketed and sold in European markets during 2025 and early 2026.1 Effective with its April 2026 shareholder meeting, the company changed its name from Mainz Biomed N.V. to Quantum Cyber N.V. and changed its Nasdaq ticker to QUCY.1
Recent corporate moves tied to the new strategy include licensing deals and an acquisition. On May 12, 2026, the company signed a license agreement with BP United, Inc. for exclusive, worldwide rights to its patents and technology, paying $1,000,000 in cash plus 20,000,000 restricted shares vesting through September 2027.1 On July 15, 2026, subsidiary Quantum Drones Corporation closed asset and property purchase agreements with Arcade Technology LLC and Arcade Realty LLC for about $4.1 million.1
Assuming a sale of 69,930,070 shares at $1.43 each, the last Nasdaq price on October 7, 2026, outstanding shares would rise to as many as 157,149,305.1 Proceeds are intended for capital expenditures on motor, propeller and quantum antenna product lines, software development, production expansion, and general corporate purposes.1 The filing also notes substantial doubt about the company's ability to continue as a going concern, as flagged in its 2025 audit report.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.